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Recent investigations (1) have revealed striking differences in the amino acid 
composition of four different human 3'G--antibodies from one individual. These 
antibodies, antilevan, antidextran,  antiteichoic acid,  and anti-blood group A 
substance,  included an antidextran of  a-(1 ~  6)  specificity.  In the  present 
study, amino acid analyses were carried out on three additional human anti- 
dextrans  of  a-(1  ~  6)  specificity  as  washed  dextran-antidextran-specific 
precipitates. In addition, antibody fractions were analyzed from three individ- 
uals who had been immunized with a dextran containing two types of antigenic 
determinants and who had formed some antibodies directed against a-(1 ~  6)- 
linked glucosyl units and others specific for a-(1 --o 2)-linked glucose residues 
(2). After precipitation of the antidextran of or-(1 ~  6) specificity with a dextran 
containing 96% of or-(1 ~  6) and 4% of a-(1 --o 3) linkages, the remaining anti- 
body was precipitated from the supernatant fluids with the homologous dextran. 
Comparison  of  the  amino  acid  composition  of  the  various  antidextrans 
of a-(1 ~  6) specificity  showed wide variations in cer  tain amino acids. Significant 
differences were also observed in the antidextran fractions from a given individ- 
ual produced against the two types of antigenic determinants. The extensive 
variations found provide further indications of the vast heterogeneity (3)  of 
human antibodies even to well defined antigenic determinants of simple struc- 
ture. 
Materials and Methods 
Antisera.--Human  antisera from six individuals were studied.  Subjects 20  mad  30  were 
injected with clinical Swedish dextrans  OP  155  and  OP  163  respectively (4),  while subject 
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Fo received native NRRL  B  512  dextran with 96% a-(1 --~ 6)- and 4% a-(1 ~  3)-linked 
glucopyranose units (5). The antibodies in these three antisera had been shown to be o~-(1 --* 
6)  specific  (6). Antisera 332 and 333 were produced by injection of dextran NRRL  ]3  1299 
S-3, antiserum R.G.M. was obtained by injecting dextran NRRL B  1424. The latter contains 
72% a-(1 ~  6) and 14% a-(1 ~  2) linkages, and NRRL B  1299 S-3 contains 50% a-(1 --* 6), 
12% or-(1 --~ 4), and 38% a-(1 ~  2) linkages (5). These three antisera had been shown to con- 
tain some a-(1 --* 6)-specific antibody and some a-(1 --* 2)-specific antibody (2). 
Isolation  of Antibodies.--Sera  were cleared by prolonged centrifugation at 4°C. Amounts 
of anfisera and dextran were chosen to give about 50 #g specific precipitate N  at the point of 
maximum  precipitation, as  determined from  quantitative precipitin curves  (2,  5).  The a- 
(1 --~ 6) antidextrans in sera 332,333, and R.G.M. were absorbed with a native B 512 dextran 
N  279. Supernatant fluids were then set up with dextran B  1424 to precipitate antibodies of 
non--a-(1 --* 6) specificity, which were largely a-(1 ~  2) specific and are so designated in the 
tables. All precipitates were washed three times with cold 0.001  ~  phosphate-buffered saline 
at pH 7.2. The washed precipitates were used directly for amino acid analyses, and for spec- 
trophotometric determination of tyrosine and tryptophan (7). 
Amino Acid Analyses.--Samples  in 12-ml centrifuge tubes were lyophilized, and dissolved 
in 0.15 ml constant boiling HC1.  The tubes were evacuated, sealed, and refluxed in toluene 
for 22, 48, and 72 hr respectively. Mter cooling, the seals were broken and HC1 was removed 
in vacuo over NaOH.  Residues were dissolved in 0.12 ml starting buffer and applied to the 
column of the amino acid  analyzer. Analyses were carried out by the method of Piez and 
Morris  (8)  as  described in  detail previously  (1).  For  spectrophotometric determination of 
tyrosine and tryptophan (7), specific  precipitates were dissolved in 0.2 ml 0.1 N NaOH and 
concentrations were adjusted to give E  values between 0.3 and 0.8 in absorption cells of  10 
mm light path. A Gilford photoelectric spectrophotometer with a Beckman DU monochroma- 
tor was used. Spectra of protein solutions can give varying amounts of irrelevant absorption 
which contribute to the E  values at a  given wavelength. These decrease with increasing wave- 
length. Therefore, values varying from 0  to 0.184 for irrelevant absorption were taken into 
account by readings obtained between 370-340 m/z plotted and extrapolated to 294.4 and 280 
m/z, as proposed by Goodwin and Morton (7). Additional determinations of tryptophan and 
phenylalanine were done by the Ba(OI-I)2  hydrolysis procedure of Noltmann et al.  (9), fol- 
lowed by automatic amino acid analyses of the alkaline hydrolysates. 
RESULTS 
Amino acid  analyses  on  the  dextran-antidextran-specific  precipitates  after 
acid  hydrolysis  for 22,  48,  and  72  hr are  presented  in Table  I,  expressed as 
moles of amino acid residues per mole (160,000)  of protein. In those cases in 
which protein hydrolysis with Ba(OH), was used, the number of phenylalanine 
residues found agreed closely with data obtained after 22 hr of acid hydrolysis. 
Spectrophotometric  determination  of tryptophan  averaged  5  residues higher 
than  values  after  alkaline  hydrolysis.  The  spectrophotometric  data  for  the 
number of tyrosine residues agreed closely with those obtained by acid hydroly- 
sis, corrected to zero time. The 22-hr hydrolytic sample of subject Fo was un- 
fortunately lost, and the 48 hr values have been used uncorrected. 
There are extensive differences in amino acid content among the antidextrans 
studied.  For all the specifc antibodies in Table I,  the differences among the 
less stable amino acids, aspartic and glutamic acid, are as large  as  14 and  16 I  I  I  I  Illfi  I  IIJ  I  I]11  I  I 
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residues respectively. Although the rate of destruction for the acid-labile amino 
acids threonine  and serine varied from one particular  antibody sample to the 
other, the differences in 22-hr values of 14 residues for threonine and 20 residues 
for serine can be taken as significant. Excluding the value of 117 residues in the 
R.G.M.  22-hr sample,  the  range  in leucine  values was only 7  residues.  Since 
these values then become intrinsically normalized for leucine, results are com- 
parable.  Among the more stable amino acids, residue differences as large as 12 
lysines,  13 glycines, 10 alanines,  17 valines, 6 histidines,  and 10 arginines were 
TABLE II 
Significant Differences  in Amino Acid Composition  of a-(1 --~ 6) Antidextrans 
R.G.M. 
im  group  ....  a +  b  -- 
nv  group  ..........  a  -- 
Glycine 
Valine 
Alanine 
Arginine 
Lysine 
Hydroxylysine 
Threonine 
Serine 
Aspartic acid 
Glutamic acid 
Proline 
Tyrosine 
Leucine 
Arginine +  lysine 
100 
131 
84 
50 
90 
118 
147 
117 
154 
105 
56 
117 
140 
333 
105 
132 
80 
45 
87 
116 
145 
119 
151 
103 
54 
109 
132 
332  30 
--  a  +  b  -- 
--  a-- 
98  98 
122  136 
87  82 
47  44 
87  89 
108  108 
137  154 
112  119 
138  147 
100  100 
51  54 
109  105 
134  133 
20 
~-b+ 
104 
132 
89 
44 
86 
122 
157 
106 
138 
99 
54 
108 
130 
Fo*  1 
a--b+  a--b- 
a~  a-- 
95  109 
119  134 
78  79 
47  48 
83  88 
--  3.2 
109 
148 
120  119 
141  149 
104  101 
50  56 
112  109 
130  136 
* 4.8-hr values. 
found among all the antidextrans  studied.  Hydroxylysine appeared  as a  con- 
stituent amino acid only in the a-(1 --~ 2)-specific antidextran of R.G.M. Max- 
imum differences of but six residues were found in proline, seven in half-cystine, 
three in methionine, six in isoleucine, three in tyrosine, and six in phenylalanine. 
The most significant differences in amino acid composition of the a-(1 --~ 6)- 
specific antibodies  are  summarized  in Table II. Values are  those  obtained at 
22 hr,  except for subject Fo for whom the 48 hr results are given. The earlier 
values on subject  1 are included together with information regarding the  Gm 
and Inv groups to which these  antibodies  belong  (10).  There  is  no apparent 
relationship of these genetic factors to the amino acid composition of antidex- 
trans.  This is hardly surprising  since the  difference between Inv (a)  and Inv DORNER, BASSETT, BEISER,  KABAT, AND TANENBAUM  827 
(b) involve but a single substitution of leucine for valine on the light chains (11) 
and perhaps Gm determinants also may involve limited substitutions. 
Table III lists the differences in amino acid composition for the a-(1 --~ 6)- 
and a-(1 --* 2)-specific populations of antidextrans from the three individuals 
studied. In general, residue differences are smaller among the a-(1 ~  2) anti- 
bodies, than among the a-(1 ~  6)-specific antidextrans in Table II. With all 
three individuals, the lysine content of the a-(1 ~  2)-specific antibody was 6- 
12 residues lower than that of a-(1 ~  6), but the a-(1 --* 2)-specific antibodies 
had a  somewhat higher arginine content than those of a-(1 --* 6) specificity. 
TABLE HI 
Significant Differences in Amino Acid Composition of Anffdergran a-(l ~  6)-and 
a-(1 --} 2)-Speeif~ Fractions  from tie Three Individuals 
Glycine 
Valine 
Alanine 
Arginine 
Lysine 
Hydroxy]ysine 
Threonine 
Serine 
Aspartic acid 
Glutamic add 
Proline 
Tyrosine 
Leucine 
Arginine +  lysine 
R.G.M. 
anti- 
a-(1 ~  6) 
100 
131 
84 
50 
90 
118 
147 
117 
154 
105 
56 
117 
140 
anti- 
~-(1  --*  2) 
111 
123 
80 
53 
78 
2.6 
112 
141 
121 
146 
99 
53 
111 
131 
333 
anti-  ]  anti- 
a-(1  ---} 6)  a-(l  ---, 2) 
105  102 
132  123 
8O  89 
45  49 
87  80 
116  115 
145  140 
119  119 
151  145 
103  102 
54  55 
109  110 
132  129 
332 
anti-  anti- 
w(1 ~  6)  a-(t --* 2) 
98  104 
122  129 
87  81 
47  54 
87  81 
108  117 
137  139 
112  122 
138  143 
100  105 
51  45 
109  110 
134  135 
With two of the samples, R.G.M. and 333, the valine content of the a-(1 ~  6) 
fraction was eight and nine residues higher than that of the a-(1 ~  2)-specific 
antibody, but with the third individual 332,  the a-(1  .-o  2)  antidextran had 
seven residues more than the a-(1 ~  6) antidextran. Similar findings may be 
seen for glutamic acid. The a-(1 --*  2)  fraction of subject 333  was higher in 
alanine than the a-(1 --~ 6) fraction, but in the other cases values were reversed. 
The sum of arginine plus lysine ranged from 129 to 140 residues, considerably 
greater than the spread of 135-141 previously reported for four antibodies from 
a single individual (1). 
DISCUSSION 
The data presented in this and in an earlier communication (1) provide evi- 
dence for variation in the amino acid composition of antibodies formed in man 828  STUDIES  ON  HUMAN  ANTIBODIES.  V 
to  carbohydrate-antigenic  determinants,  since  significant  differences  were 
found in 13 amino acids of the 18 measured (Table I). The variation in numbers 
of residues  of certain  amino  acids  among antibodies  of different  specificities 
formed by a  single individual is as great as the variation which  can occur in 
antibodies of the same specificity (antidextran) from different individuals. These 
amino acids include  glycine, lysine,  threonine,  proline,  tyrosine,  and leucine. 
However, the range in valine among the seven antidextrans was only 17 residues 
(Table II), while that for the four antibodies from one person was 32  residues 
(Table IV, column seven). With respect to alanine,  serine,  aspartic acid,  and 
TABLE IV 
Maximum  Variation  in Number of Amino Acid Residues  Encountered 
Amino acid 
Glycine 
Valine 
Alanine 
Arginine 
Lysine 
Threonine 
Serine 
Aspartic acid 
Glutamic acid 
Proline 
Tyrosine 
Leucine 
Four 
antibodies in 
one person 
20 
32 
6 
13 
15 
17 
10 
6 
3 
7 
10 
7 
Total range 
of 
antldextran 
16 
17 
11 
9 
12 
18 
20 
16 
16 
6 
11 
7 
Seven 
individuals 
a-(1 --~ 6) 
anfidextmn 
10 
17 
11 
6 
7 
14 
20 
14 
16 
6 
6 
7 
+ 
7 
10 
7 
5 
3 
10 
0 
7 
6 
5 
5 
0 
Three 
individuals 
a-(l -* 2) 
9 
6 
9 
5 
3 
5 
2 
3 
3 
6 
10 
1 
a-(l  --~ 6) 
versus 
a-(1 --* 2) 
for any 
individual 
11 
9 
9 
7 
12 
9 
6 
10 
8 
6 
6 
1 
glutamic acid the different antibodies from one individual  showed much less 
variation than did the antidextrans from different individuals.  The ranges for 
the two groups with respect to glycine and arginine may not be significant. If 
one compares the range for each amino acid among the an  tidextrans of a-(1 --~ 6) 
specificity (Table IV, column  four), it is evident  that  the  same relationships 
hold as for all of the antidextrans, except that the glycine range is but 10 resi- 
dues as compared with 20 for the four different antibodies. 
In columns five and six in Table IV are given the ranges in the oz-(1 ~  6)- 
and a-(1 --~ 2)-specific antibodies formed in the same three individuals.  The 
valine, threonine, serine, and glutamic acid variation is greater for the a-(1 --~ 6) 
antidextran, while the range in tyrosine is greater for the ~-(1 --~ 2) antibody. 
Table IV,  column  seven tabulates  the  maximum differences for each  amino 
acid between the a-(1 --~ 6) and a-(1 -~ 2) antibodies in a given individual. The DORNER, BASSETT~ BEISER~ KABAT, AND TANEN'BAUM  829 
differences  are much greater, except for tyrosine, for the ~x-(1 ---> 6) antibodies 
than for the o~-41 ~  2)-specific antibody among the three individuals,  especially 
in lysine,  aspartic acid,  and  glutamic  acid.  None of these antibody fractions 
represent  homogeneous  populations  of  antibody  molecules  especially with 
respect to their antibody-combining sites.  They may, however, be relatively 
more homogeneous  than  the  whole human  "yG-immunoglobulin  as  a  conse- 
quence of the antigenic stimulus which causes selection of the antibody-forming 
cells, and hence of "yG-molecules, with respect to the Gm factors and their H 
and L chains. As in the earlier study, 41), there is no direct basis for attributing 
the large differences found to the combining sites of these antibodies. 
The extensive variations in amiuo acid composition of the human antibodies 
is in contradistinction to the relatively small differences reported by Koshland 
(12)  for rabbit  antibodies.  Two possible interpretations  come to mind  with 
respect to these differences.  4  a) Rabbit antibodies and rabbit immunoglobulins 
may be intrinsically more homogeneous  than  human  antibodies and ~,G-im- 
munoglobvllns,  although  the antibodies studied have also been shown to be 
heterogeneous with respect to their antibody-combining sites 413; cf.  14).  (b) 
The relatively intensive antigenic stimulation generally employed with animals 
as compared to the minimal stimulation used in humans may have resulted in 
the mobilization of most types of cells forming ~,G-antibody in the rabbit, there- 
by giving rise to populations of antibody molecules to the various antigens in 
which the differences in amino acid composition are averaged. 
Studies on human myeloma and Bence Jones proteins show that even these 
selected populations of molecules  and their constituent chains  are not homo- 
geneous.  Thus, Terry et ai. (15) have reported that myeloma proteins give as 
many as eight light and nine heavy chain bands in disc electrophoresis.  Normal 
~/G-immunoglobulin  is even more heterogeneous with respect to the number of 
heavy and light chain bands which it gives in disc or starch gel electrophoresis 
416, 17). Grey and Kunkel (18), and Terry and Fahey (19) have shown that 
myeloma globulins can be classified into four subgroups based on immunological 
differences  among their heavy chains and that these differences correlate with 
the Gm genetic factors on the heavy chain  420). The light chains  may be of 
two antigenic  varieties, K  and L, the specificities  of each involving multiple 
antigenic determinants.  In addition, the various purified  antibodies as well as 
myeloma proteins have been shown to possess unique antigenic determinants 
which endow them with individual specificity (21). All of these differences may 
be indicative of great variation in amino acid composition and sequence for the 
myeloma proteins  and  antibodies.  Studies on  human  antidextran  (22)  have 
shown them to be mixtures of molecules  with both K  and L  light chains,  to 
be different in heavy chain subgroups, and also to show individual specificity. 
There is thus ample evidence based upon these parameters to justify the varia- 
tions in amino acid composition found. 830  STUDIES  ON  HI]MAN  ANT]BODIES.  V 
Sequence determinations on isolated individual Bence Jones proteins (11,  23, 
24) have shown that variations are confined to the amino terminal half of the 
molecule, the carboxy terminal portion being constant except for the leucine- 
valine substitution  (25,  26)  on residue  1911 which is responsible for the Inv(a) 
and Inv(b) specificity, respectively. Similarly, studies of heavy chains and papain 
fragments  of ~G-immunoglobulin  have  established  that  the  amino  terminal 
portion of the Fd fragment is also variable in amino acid sequence. Many of the 
sequence  and  compositional  differences  must  have  no  relation  to  antibody 
specificity or to the antibody-combining site. Since human antidextran (2, 27) 
and other antibodies are known to be populations of molecules with combining 
sites which vary in size and in specificity, these differences too may be respon- 
sible for some of the variation in composition observed. 
SUMMARY 
Human  dextran-antidextran-specific  precipitates from individuals  immun- 
ized with dextrans containing either one or two antigenic determinants,  were 
analyzed for their content of various amino acids. Large differences in certain 
amino acids were found among a-(1 ~  6)-specific antidextrans. Wide variations 
were  also  observed in  antidextran  fractions from a  given individual  specific 
for a-(1 -~ 6)- and a-(1 --~ 2)-linked glucose residues. 
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